(Reuters Health) – The budget impact to Medicaid of gene therapy to treat severe sickle cell disease offers a window on the potential costs of this emerging class of million-dollar treatments, and requires payers to think about how to ensure…
Read MoreMIT researchers use AI to find drugs that could be repurposed for COVID-19
The Massachusetts Institute of Technology announced this week that researchers had used machine learning to identify medications that may be repurposed to fight COVID-19. “Making new drugs takes forever,” Caroline Uhler, a computational biologist in MIT’s Department of Electrical…
Read MorePittsburgh Health Data Alliance developing new AI models for oncology, mental health
More than a year since they announced a partnership to advance machine learning advancement in areas such as oncology, precision medicine and imaging, the researchers from the Pittsburgh Health Data Alliance and AWS are unveiling new AI-based techniques to assess breast cancer risk,…
Read MoreResearchers at Mount Sinai use AI to detect COVID-19 in lung scans
Researchers from New York-based Mount Sinai Health System have combined artificial intelligence, imaging and clinical data to rapidly detect COVID-19 in patients. In a study published this week in Nature Medicine, researchers used AI algorithms in conjunction with chest CT…
Read MoreUsing machine learning, Immunai plans to map immune system
New York-based startup Immunai launched out of stealth Thursday, announcing its plan to map the immune system and improve diagnosis and treatment of disease. According to the company’s founders, Immunai has already used single-cell technologies and machine learning algorithms to…
Read More